We are live on ! Find out more
RCP

Rho Capital Partners Portfolio holdings

AUM $20.4M
This Fund
S&P 500
This Quarter Est. Return
-30.69%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
-$108M
Cap. Flow
+$4.17M
Cap. Flow %
2.29%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$3.32M
2
SENS icon
Senseonics Holdings Inc
SENS
+$1.3M

Top Sells

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$447K

Sector Composition

Rank Sector Weight
1 Technology 27.14%
2 Healthcare 21.82%
3 Communication Services 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAC
1
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$57.1M 31.25%
1,067,892
– –
IL
2
DELISTED
IntraLinks Holdings Inc.
IL
$49.6M 27.14%
6,290,503
– –
EVDY
3
DELISTED
Everyday Health, Inc.
EVDY
$23M 12.59%
4,107,522
– –
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$352M
$19.4M 10.65%
656,948
– –
TVRD
5
Tvardi Therapeutics
TVRD
$23.7M
$19.1M 10.45%
85,224
+11,111
+15% +$3.32M
MGNI icon
6
Magnite
MGNI
$2.66B
$8M 4.38%
437,390
-29,226
-6% -$447K
RLOC
7
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$4.6M 2.52%
2,570,395
– –
SENS icon
8
Senseonics Holdings Inc
SENS
$257M
$1.32M 0.73%
+23,140
New +$1.3M
NRX
9
DELISTED
NEPHROGENEX INC COM
NRX
$495K 0.27%
1,052,966
– –
XCOM
10
DELISTED
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
$38K 0.02%
13,366
– –

Similar funds

LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

Rho Capital Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Rho Capital Partners held 10 positions worth $183M, down 37% from $291M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Rho Capital Partners's Q1 2016 filing shows 1 new, 1 increased and 1 reduced positions. Its largest new stake was Senseonics Holdings Inc: 23,140 shares worth $1.32M. The largest sale was Magnite, an estimated $447K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.

  • Rho Capital Partners's largest Q1 2016 buy was Senseonics Holdings Inc: 23,140 shares worth $1.32M.
  • Rho Capital Partners added most to Tvardi Therapeutics in Q1 2016, an estimated $3.32M increase.
  • Rho Capital Partners's biggest Q1 2016 reduction was Magnite, cutting an estimated $447K.
  • Rho Capital Partners's ten largest holdings make up 100% of its $183M portfolio in Q1 2016.
  • Rho Capital Partners opened 1 new position and closed 0 in Q1 2016.
  • Rho Capital Partners's portfolio value fell 37% quarter-over-quarter to $183M.

Based on Rho Capital Partners's 13F filing for Q1 2016, filed 9 May 2016.